Chia Yi Su Lab Join Us To Fight Cancer
Chia Yi Su Ms In Accountancy Student Uiuc Linkedin We are grateful for the interest and enthusiasm from students around the world who wish to join our lab. however, our lab has reached full capacity for the 2026 academic year. Fingerprint dive into the research topics where chia yi su is active. these topic labels come from the works of this person. together they form a unique fingerprint.
Purdue Researchers Fight Cancer Stories Monoamine oxidase b expression correlates with a poor prognosis in colorectal cancer patients and is significantly associated with epithelial to mesenchymal transition related … js chang, cy. Recently, exocytic rabs have received increasing attention in cancer research. however, the functional roles of exocytic rabs in colorectal carcinogenesis remain to be elucidated. assistant professor, national yang ming chiao tung university cited by 1,495 biomedical engineering cancer biology pathology. Our study revealed that rab3c overexpression promotes tumor metastasis and is associated with poor prognosis in colorectal cancer, through modulating the ability of cancer cells to release il 6.
Chia Yi Su Lab Join Us To Fight Cancer assistant professor, national yang ming chiao tung university cited by 1,495 biomedical engineering cancer biology pathology. Our study revealed that rab3c overexpression promotes tumor metastasis and is associated with poor prognosis in colorectal cancer, through modulating the ability of cancer cells to release il 6. In this review, recent advances in engineered tumor microenvironments to advance cancer research and drug discovery are presented, including tumor spheroids, microfluidic chips, paper scaffolds, hydrogel‐based engineered tissues, 3d bioprinted scaffolds and multiscale topography. Chia yi su is on facebook. join facebook to connect with chia yi su and others you may know. facebook gives people the power to share and makes the world. Returning to taiwan, she established the cancer engineering lab, which is dedicated to developing innovative therapies for cancer recurrence and metastasis through integrating biomedical and engineering approaches. We developed a hybrid nanopatterned model to study breast cancer cell clusters at the migration front with aligned stromal topography. our findings revealed that topography induces drug resistance of breast cancer cell clusters to chemotherapy drugs by activating the ahr cyp1 pathways.
Comments are closed.